Gap, Inc. (GPS) Says Has Decided to Wind Down Partnership With Kanye West - DJ, Citing Memo
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Kanye West seeks to end apparel partnership with Gap
September 15, 2022 9:19 AM EDTBy Deborah Mary Sophia and Uday Sampath Kumar
(Reuters) -Kanye West's lawyers on Thursday sent a letter to Gap Inc notifying the apparel chain that the rapper and fashion designer was terminating his partnership with the company, saying it failed to meet its obligations under the contract.
Gap breached its agreement with West by not selling the Yeezy Gap-branded products at its brick-and-mortar outlets and failing to open dedicated stores for the brand, the letter, viewed by Reuters, said.
... MoreGap (GPS) Stock Falls on Report Kanye West is Terminating Yeezy Gap Partnership
September 15, 2022 9:19 AM EDTShares of Gap (NYSE: GPS) are down 3.5% in premarket trading after the Wall Street Journal reported that rapper and entrepreneur Kanye West formally informed the company that he is terminating their partnership.
Wests lawyers reportedly sent a letter to Gap to notify them theyre terminating the collaboration due to the contract break.... More
Pre-Open Movers: Adobe Sinks on Deal to Acquire Figma, STOR Surges on Takeover
September 15, 2022 9:17 AM EDTPre-Open Stock Movers:
Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) 48% LOWER; announced topline results from the Phase 2 clinical trial of ELX-02 in combination with ivacaftor in Class 1 cystic fibrosis (CF) patients with at least one nonsense mutation. The combination trial of ELX-02 with ivacaftor was well tolerated but did not achieve statistical significance for efficacy endpoints, including changes from baseline in sweat chloride concentration (SCC) and percent forced expiratory volume (FEV1).
Kanye West Notifies Gap (GPS) He Is Terminating Partnership - DJ
September 15, 2022 9:01 AM EDT(Updated - September 15, 2022 9:08 AM EDT)
Kanye West notified Gap, (NYSE: GPS) that he is terminating his partnership, according to the Dow Jones, citing a netter.
Lawyers for West sent a letter to Gap notifying the company that his Yeezy LLC is... More
